Skip to main content

Start-up that uses wearables to track whether drugs are effective gets $100 million infusion led by SoftBank

SoftBank's investment into Biofourmis strikes a note of optimism for the troubled digital therapeutics space.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.